Unusual association of myasthenia gravis and ulcerative colitis in a 14-year-old boy

C Guinet-Charpentier1, C Bilbault2, A Kennel3

  • 1Inserm U954, service d'hépato-gastro-entérologie, hôpital d'enfants, CHU Nancy-Brabois, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.

Insights

Ulcerative colitis (UC) is a chronic inflammatory bowel disease. This case highlights a rare association of UC with multiple autoimmune disorders, including myasthenia gravis, in a pediatric patient.

Area of Science:

  • Gastroenterology and Immunology
  • Pediatric Inflammatory Bowel Disease (IBD)
  • Autoimmune Disorders

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon, with a notable incidence in the pediatric population.
  • Extradigestive manifestations are common in inflammatory bowel disease (IBD), but neurologic complications are infrequently reported.
  • Early diagnosis and management are crucial for improving long-term outcomes in pediatric IBD patients.

Observation:

  • A 14-year-old boy was diagnosed with ulcerative colitis (UC).
  • Subsequently, he developed autoimmune hepatitis with primary sclerosing cholangitis.
  • Two months later, he was diagnosed with myasthenia gravis, a distinct autoimmune condition.

Findings:

  • This case illustrates a rare clustering of multiple autoimmune diseases in a single pediatric patient with IBD.
  • The patient presented with ulcerative colitis, autoimmune hepatitis, primary sclerosing cholangitis, and myasthenia gravis.
  • The temporal association suggests a potential link between these autoimmune conditions.

Implications:

  • Physicians should maintain a high index of suspicion for concurrent autoimmune disorders in pediatric IBD patients.
  • Early recognition and integrated management of associated autoimmune conditions may improve patient prognosis.
  • Further research is warranted to elucidate the underlying mechanisms connecting IBD and other autoimmune diseases.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
17
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
19
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.6K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
684